In a significant breakthrough, researchers have developed COVID-19 eliminative Short Peptide Inhibiting ACE2 binding ...

has developed COVID-19 eliminative Short Peptide Inhibiting ACE2 binding (CeSPIACE), a mutation-tolerant spike protein inhibitor that remains effective against SARS-CoV-2 variants, including Omicron ...

SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 (ACE2) receptors ... including Omicron XBB.1.5. The study was ...

SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 (ACE2) receptors ... including Omicron XBB.1.5. The study was ...